Compare TONX & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TONX | TKNO |
|---|---|---|
| Founded | N/A | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.4M | 236.6M |
| IPO Year | N/A | 2021 |
| Metric | TONX | TKNO |
|---|---|---|
| Price | $3.06 | $4.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 715.7K | 160.2K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 7.29 | N/A |
| Revenue | $7,760,000.00 | ★ $39,801,000.00 |
| Revenue This Year | $526.82 | $8.79 |
| Revenue Next Year | $45.45 | $10.52 |
| P/E Ratio | $0.42 | ★ N/A |
| Revenue Growth | ★ 3760.70 | 9.50 |
| 52 Week Low | $2.73 | $3.94 |
| 52 Week High | $29.77 | $10.37 |
| Indicator | TONX | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 50.69 |
| Support Level | N/A | $4.41 |
| Resistance Level | N/A | $4.87 |
| Average True Range (ATR) | 0.00 | 0.29 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 0.00 | 86.81 |
TON Strategy Co is a leader in interactive video-based sales applications, transforms how businesses attract and engage customers. The company's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.